ACM
RNAM

Aquatic Capital Management’s Avidity Biosciences RNAM Stock Holding History

Aquatic Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-62,130
Closed -$1.76M – 1622
2025
Q2 		$1.76M Buy
+62,130
New +$1.85M 0.04% 503
2025
Q1 		– Sell
-60,641
Closed -$1.76M – 1577
2024
Q4 		$1.76M Buy
+60,641
New +$2.53M 0.05% 404
2024
Q3 		– Sell
-34,996
Closed -$1.43M – 1479
2024
Q2 		$1.43M Buy
+34,996
New +$1M 0.05% 329
2023
Q3 		– Sell
-5,500
Closed -$61K – 1586
2023
Q2 		$61K Buy
+5,500
New +$69K ﹤0.01% 953

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aquatic Capital Management's RNAM Position: Q3 2025 in Review

Aquatic Capital Management sold out of Avidity Biosciences (RNAM) in Q3 2025, closing a stake of 62,130 shares — an estimated $1.76M sold.

Aquatic Capital Management first reported a position in RNAM in Q2 2023 and held it in 4 quarters. The position peaked at $1.76M in Q2 2025. 272 funds tracked by Wall St. Rank hold RNAM as of Q3 2025.

  • Aquatic Capital Management reported no remaining Avidity Biosciences position as of Q3 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 62,130 Avidity Biosciences shares in Q3 2025, an estimated $1.76M.
  • Aquatic Capital Management first reported a position in Avidity Biosciences in Q2 2023 and held it in 4 quarters.
  • Aquatic Capital Management's Avidity Biosciences position peaked at $1.76M in Q2 2025.
  • 272 funds tracked by Wall St. Rank held Avidity Biosciences as of Q3 2025.

Based on Aquatic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.